Table 1.
Demographic and clinical characteristics of the PD patients and controls.
| LPD | RPD | Controls | P value | |
|---|---|---|---|---|
| Number of subjects | 30 | 27 | 32 | |
| Age | 62.63 ± 8.88 | 65.85 ± 6.982 | 62.41 ± 7.07 | 0.056 |
| Gender (male/female) | 14/16 | 14/13 | 16/16 | 0.924 |
| Disease duration | 6.80 ± 3.62 | 6.15 ± 3.59 | 0.499 | |
| Hoehn–Yahr staging | 2.13 ± 0.71 | 2.28 ± 0.67 | 0.416 | |
| UPDRS III | 30.90 ± 12.59 | 29.67 ± 19.09 | 0.676 | |
| HAMD | 9.07 ± 5.27 | 9.56 ± 5.09 | 0.724 | |
| HAMA | 9.93 ± 5.04 | 10.52 ± 6.03 | 0.691 | |
| NMSQ | 11.07 ± 5.77 | 11.56 ± 4.86 | 0.732 |
HAMA, Hamilton Anxiety Rating Scale; HAMD, Hamilton Depression Rating Scale; LPD, Parkinson's disease with left onset; RPD, Parkinson's disease with right onset; NMSQ, Nonmotor Symptoms Questionnaire; and UPDRS, Unified Parkinson's Disease Rating Scale.